Amended Statement of Changes in Beneficial Ownership (4/a)
May 17 2016 - 4:28PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Williams Michael J PhD
|
2. Issuer Name
and
Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE
[
IDXX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive Vice President
|
(Last)
(First)
(Middle)
ONE IDEXX DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/14/2016
|
(Street)
WESTBROOK, ME 04092
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
2/17/2016
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
2/14/2016
|
|
M
|
|
514
|
A
|
$0
|
40856
(1)
|
D
|
|
Common Stock
|
2/14/2016
|
|
M
|
|
514
|
A
|
$0
|
41370
|
D
|
|
Common Stock
|
2/14/2016
|
|
M
|
|
545
|
A
|
$0
|
41915
|
D
|
|
Common Stock
|
2/14/2016
|
|
M
|
|
403
|
A
|
$0
|
42318
|
D
|
|
Common Stock
|
2/14/2016
|
|
M
|
|
472
|
A
|
$0
|
42790
|
D
|
|
Common Stock
|
2/14/2016
|
|
F
|
|
779
|
D
|
$67.85
(2)
|
42011
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Non-Qualified Stock Option (right-to-buy)
|
$67.85
|
2/14/2016
|
|
A
|
|
41259
(11)
|
|
(3)
|
2/13/2026
|
Common Stock
|
41259
|
(10)
|
41259
|
D
|
|
Incentive Stock Option (right-to-buy)
|
$67.85
|
2/14/2016
|
|
A
|
|
1476
|
|
(3)
|
(3)
|
Common Stock
|
1476
|
(10)
|
1476
|
D
|
|
Restricted Stock Unit
|
(4)
|
2/14/2016
|
|
A
|
|
3685
|
|
(4)
|
(4)
|
Common Stock
|
3685
|
(10)
|
16313
|
D
|
|
Restricted Stock Unit
|
(5)
|
2/14/2016
|
|
M
|
|
|
514
|
(5)
|
(5)
|
Common Stock
|
514
|
(10)
|
15799
|
D
|
|
Common Stock
|
(6)
|
2/14/2016
|
|
M
|
|
|
514
|
(6)
|
(6)
|
Common Stock
|
514
|
(10)
|
15285
|
D
|
|
Restricted Stock Unit
|
(7)
|
2/14/2016
|
|
M
|
|
|
545
|
(7)
|
(7)
|
Common Stock
|
545
|
(10)
|
14740
|
D
|
|
Common Stock
|
(8)
|
2/14/2016
|
|
M
|
|
|
403
|
(8)
|
(8)
|
Common Stock
|
403
|
(10)
|
14337
|
D
|
|
Common Stock
|
(9)
|
2/14/2016
|
|
M
|
|
|
472
|
(9)
|
(9)
|
Common Stock
|
472
|
(10)
|
13865
|
D
|
|
Explanation of Responses:
|
(
1)
|
Includes 84 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2015.
|
(
2)
|
Closing price of Issuer's common stock on the NASDAQ market on February 12, 2016.
|
(
3)
|
Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017.
|
(
4)
|
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.
|
(
5)
|
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2012 and has been adjusted to reflect the the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").
|
(
6)
|
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2013 and has been adjusted to reflect the Stock Split.
|
(
7)
|
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014 and has been adjusted to reflect the Stock Split.
|
(
8)
|
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split.
|
(
9)
|
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.
|
(
10)
|
Not applicable.
|
(
11)
|
Amendment filed to correct a typographical error in the previously reported number of stock options awarded.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Williams Michael J PhD
ONE IDEXX DRIVE
WESTBROOK, ME 04092
|
|
|
Executive Vice President
|
|
Signatures
|
/s/ Lily J. Lu, Attorney-in-Fact for Michael J. Williams, PhD
|
|
5/17/2016
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From Aug 2024 to Sep 2024
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From Sep 2023 to Sep 2024